US 11,654,175 B2
Elsholtzia ciliata essential oil extract as antiarrhythmic drug
Jurga Bernatoniene, Kaunas (LT); Lauryna Pudziuvelyte, Kaunas (LT); Jonas Jurevicius, Kaunas (LT); Regina Macianskiene, Kaunas (LT); and Sandrita Simonyte, Kaunas (LT)
Assigned to LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS, Kaunas (LT)
Appl. No. 16/982,769
Filed by LIETUVOS SVEIKATOS MOKSLŲ UNIVERSITETAS, Kaunas (LT)
PCT Filed Apr. 6, 2018, PCT No. PCT/IB2018/052396
§ 371(c)(1), (2) Date Sep. 21, 2020,
PCT Pub. No. WO2019/193400, PCT Pub. Date Oct. 10, 2019.
Prior Publication US 2021/0008141 A1, Jan. 14, 2021
Int. Cl. A61K 36/53 (2006.01); A61K 47/26 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01)
CPC A61K 36/53 (2013.01) [A61K 47/26 (2013.01); A61K 9/0053 (2013.01); A61K 9/107 (2013.01)] 4 Claims
 
1. A method for treating a human patient for cardiac arrythmias comprising the steps of:
extracting dried leaves of Elsholtzia ciliata herb by hydrodistillation;
mixing an amount of 10-80 ml of said Elsholtzia ciliata oil extract with 10-80 ml emulsifier polysorbate 20;
adding 20-80 mL pure water and mixing to form an anti-arrythmic composition; and
administering the anti-arrythmic composition to the human patient for treating and preventing cardiac arrhythmias.